Home News Organisation Data collection Quality Monitoring Research(ers) Treating physicians Patients Employment Links FAQ Contact Disclaimer Login Presentaties in 2009 Presentaties Transmission networks of (resistant) HIV-1 among MSM in the Netherlands Daniela Bezemer Amsterdam, 24 november 2009   In patients on cART without an undetectable viral load measured in the last three months the use of condoms is crucial to reduce HIV transmission Colette Smit Amsterdam, 24 november 2009   Episodes of HIV viremia and the risk of non-AIDS events amongst successfully treated patients Shuangjie Zhang Amsterdam, 24 november 2009   Controlling the HIV epidemic in the Netherlands Frank de Wolf Keulen, Duitsland, 11-14 november 2009   Immuno-virological response to triple NRTI and boosted PI in treatment-naïve HIV-2-infected patients. The ACHIEV2E collaboration study group. Keulen, Duitsland, 11-14 november 2009   Mortality rates of elderly HIV-infected adult treated with antiretroviral are closer to general population than in younger patients. C Lewden on behalf of the COHERE Mortality Working Group Keulen, Duitsland, 11-14 november 2009   CD4 Count, Viral Suppression, Prophylaxis and the Risk of Recurrent Pneumocystis Pneumonia in the cART Era The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) A Mocroft for the Opportunistic Infections Working Group Keulen, Duitsland, 11-14 november 2009   Longer duration of exposure to immunodeficiency and detectable viremia: both are risk factors for non-AIDS defining malignancies in HIV-1 infected patients on combination antiretroviral therapy Anouk Kesselring Cape Town, Zuid Africa, 19-22 juli 2009   HIV in NL schatting-1 Ard van Sighem Bilthoven, 12 juni 2009   Verschuiving van de hepatitis C epidemie onder HIV-patienten; van injecterend drugsgebruik naar homoseksueel contact. Welling C, de Wolf F, Smit C Amsterdam, 11-12 juni 2009   Limited impact of episodes of viremia on the risk of non-AIDS events amongst successfully treated patients Shuangjie Zhang Amsterdam, mei 2009   Trend in antiretrovirale therapie (ART) regimes; Draagt ART bij aan de preventie van HIV-1 infectie? Frank de Wolf Curaçao, 18 - 20 april 2009   De rol van Stichting HIV Monitoring bij onderzoek: late presentatie in kliniek zorgt voor gelimiteerd effect van ART. Frank de Wolf Curaçao, 18 - 20 april 2009   Controlling the HIV epidemic in the Netherlands Frank de Wolf Lissabon, Portugal, 26-28 maart 2009   Limited impact of episodes of viremia on the risk of non-AIDS events amongst successfully treated patients Shuangjie Zhang Lissabon, Portugal, 26-28 maart 2009   Ageing with HIV Ard van Sighem Amsterdam, 11 januari 2009   Poster presentaties Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands Luuk Gras Luuk Gras, Suzanne Jurriaans, Margreet Bakker, Ard van Sighem, Daniela Bezemer, Christophe Fraser, Joep Lange, Jan M. Prins, Ben Berkhout, Frank de Wolf, on behalf of the ATHENA national observational cohort study Amsterdam, 24 november 2009   Serious non-AIDS events are increasingly more common than AIDS events in the HIV-1 cART treated population Luuk Gras Anouk Kesselring, Luuk Gras, Colette Smit, Frank de Wolf, Peter Reiss, Ferdinand Wit Amsterdam, 24 november 2009   Immunodeficiency is a risk factor for non-AIDS defining malignancies in HIV-1 infected patients on combination antiretroviral therapy. Anouk Kesselring Anouk Kesselring, Luuk Gras, Colette Smit, Frank de Wolf, Peter Reiss, Ferdinand Wit Amsterdam, 24 november 2009   Estimating the number of people living with HIV/AIDS in the Netherlands Ard van Sighem Ard van Sighem, Christophe Fraser, Daniela Bezemer, Geoff Garnett, Frank de Wolf Amsterdam, 24 november 2009   Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals Ard van Sighem A van Sighem, Luuk Gras, Peter Reiss, Kees Brinkman, Frank de Wolf Amsterdam, 24 november 2009   Significant increase in the number of HIV-infected homosexual men, co-infected with hepatitis C. Camiel Welling Camiel A.H. Welling, Colette Smit, Jan T.M. van der Meer, Kees Brinkman, Andy I.M. Hoepelman, Frank de Wolf Amsterdam, 24 november 2009   The effectiveness of national first trimester opt-out HIV screening in the Netherlands K Boer, C Smit, M van der Flier, F de Wolf Amsterdam, 24 november 2009   Effectiveness of antenatal screening for HIV, hepatitis B and syphilis in the Netherlands E op de Coul, Y van Weert, P Oomen, C Smit, K van der Ploeg, M van der Sande Amsterdam, 24 november 2009   Presence of drug resistance during the course of treatment in patients who developed virologic failure to the three original classes of antiretroviral drug Frank de Wolf, on behalf of the PLATO II Project Team of COHERE Keulen, Duitsland, 11-14 november 2009   HIV-related Hodgkin lymphoma in the era of HAART: Incidence and survival in a European multi-cohort study, preliminary results J Bohlius, for the cancer Working Group of COHERE Keulen, Duitsland, 11-14 november 2009   Viral load outcome after virologic failure of the three original antiretroviral drug classes in 2000-2007 D Costagliola, for the PLATO II Project Team of COHERE Keulen, Duitsland, 11-14 november 2009   Measuring the quality of data collection in a large observational cohort of HIV and AIDS Mariska Hillebregt Mariska Hillebregt, Elly de Lange-De Klerk, Dirk Knol, Frank de Wolf, Colette Smit   Interaction between hepatitis B and C in hiv infected patients; risk of dying among patients with a triple infection Colette Smit Kopenhagen, Denemarken, 22-26 april 2009   Newly acquired hepatitis C infection causes a cellular immune response amongst HIV infected individuals Colette Smit Lissabon, Portugal, 26-28 maart 2009   A novel method of estimating the number of people living with HIV/AIDS in the Netherlands. Ard van Sighem Lissabon, Portugal, 26-28 maart 2009   Lower HIV RNA measurement frequency introduces misclassification of episodes of viraemia in initially successfully treated patients Luuk Gras Lissabon, Portugal, 26-28 maart 2009   Immune restoration and onset of new AIDS-defining events after starting cART in HIV-1 infected immigrants from sub-Saharan Africa in the Netherlands. Anouk Kesselring Lissabon, Portugal, 26-28 maart 2009   Set Point HIV-1 Viral Load Is Higher in Patients in the Netherlands in More Recent Years Luuk Gras Luuk Gras, Suzanne Jurriaans, Margreet Bakker, Ard van Sighem, Daniela Bezemer, Christophe Fraser, Colette Smit, Joep Lange, Jan M. Prins, Ben Berkhout, Frank de Wolf   Modelling 27 Years of the HIV-1 Epidemic amongst Men Having Sex with Men Daniela Bezemer Daniela Bezemer, Frank de Wolf, Maarten C. Boerlijst, Ard van Sighem, T. Deirdre Hollingsworth, and Christophe Fraser   Transmission Networks of Resistant HIV-1 among Men Who Have Sex with Men: The Netherlands Daniela Bezemer Daniela Bezemer, Ard van Sighem, Vladimir V. Lukashov, Lia van der Hoek, Nicole Back, Rob Schuurman, Charles A.B. Boucher, Eric Claas, Maarten C. Boerlijst, Roel A. Coutinho, Frank de Wolf   Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy. Anouk Kesselring Anouk Kesselring, Ferdinand Wit, Caroline Sabin, Jens Lundgren, John Gill, Jose Gatell, Andri Rauch, Julio Montaner , Frank de Wolf, Peter Reiss and Amanda Mocroft on behalf of the Nevirapine Toxicity Multicohort Collaboration.   Stable HIV-1 Epidemic among Heterosexual Men and Women in the Netherlands Ard van Sighem Ard van Sighem, Christophe Fraser, Daniela Bezemer, Suzanne Jurriaans, Geoff Garnett, Frank de Wolf   Different Rates of Discontinuation because of Toxicities According to CD4 Counts and Prior ART in Patients Starting Neviraprine-based cART: Nevirapine Toxicity Multicohort Collaboration Anouk Kesselring Anouk Kesselring, Ferdinand Wit, Caroline Sabin, Jens Lundgren, John Gill, Jose Gatell, Andri Rauch, Julio Montaner , Frank de Wolf, Peter Reiss and Amanda Mocroft on behalf of the Nevirapine Toxicity Multicohort Collaboration   Risk of extensive triple-class virologic failure of the three original antiretroviral drug classes among people followed from therapy initiation with NNRTI or ritonavir-boosted Protease Inhibitor regimens R Lodwick and Plato II projectteam of COHERE   Side effects of HAART in HIV-1 infected pregnant and non-pregnant women; pregnancy is associated with hepatotoxicity, while ethnicity is associated with rash. I Snijdewind, C Smit, M Godfried, J Nellen, K Boer, F de Wolf, I van der Ende.   Copyright © 2010 Stichting HIV Monitoring Website realisatie en CMS door Glimworm